BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29037911)

  • 1. Assessing daylight & low-dose rate photodynamic therapy efficacy, using biomarkers of photophysical, biochemical and biological damage metrics in situ.
    de Souza ALR; LaRochelle E; Marra K; Gunn J; Davis SC; Samkoe KS; Chapman MS; Maytin EV; Hasan T; Pogue BW
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():227-233. PubMed ID: 29037911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Blue and White Lamp Light with Sunlight for Daylight-Mediated, 5-ALA Photodynamic Therapy, in vivo.
    Marra K; LaRochelle EP; Chapman MS; Hoopes PJ; Lukovits K; Maytin EV; Hasan T; Pogue BW
    Photochem Photobiol; 2018 Sep; 94(5):1049-1057. PubMed ID: 29663426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying the radiant exposure and effective dose in patients treated for actinic keratoses with topical photodynamic therapy using daylight and LED white light.
    Manley M; Collins P; Gray L; O'Gorman S; McCavana J
    Phys Med Biol; 2018 Jan; 63(3):035013. PubMed ID: 29192611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations.
    Wiegell SR; Fabricius S; Heydenreich J; Enk CD; Rosso S; Bäumler W; Baldursson BT; Wulf HC
    Br J Dermatol; 2013 Jan; 168(1):186-91. PubMed ID: 22860885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling PpIX effective light fluence at depths into the skin for PDT dose comparison.
    LaRochelle EPM; Marra K; LeBlanc RE; Chapman MS; Maytin EV; Pogue BW
    Photodiagnosis Photodyn Ther; 2019 Mar; 25():425-435. PubMed ID: 30685548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
    de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
    Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
    Mikolajewska P; Iani V; Juzeniene A; Moan J
    Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective fluence and dose at skin depth of daylight and lamp sources for PpIX-based photodynamic therapy.
    Ruiz AJ; LaRochelle EPM; Samkoe KS; Chapman MS; Pogue BW
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103260. PubMed ID: 36627070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light protection of the skin after photodynamic therapy reduces inflammation: an unblinded randomized controlled study.
    Petersen B; Wiegell SR; Wulf HC
    Br J Dermatol; 2014 Jul; 171(1):175-8. PubMed ID: 24506809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
    Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin.
    Robinson DJ; de Bruijn HS; Star WM; Sterenborg HJ
    Photochem Photobiol; 2003 Mar; 77(3):319-23. PubMed ID: 12685661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-fluence rate, long duration photodynamic therapy in glioma mouse model using organic light emitting diode (OLED).
    Guo HW; Lin LT; Chen PH; Ho MH; Huang WT; Lee YJ; Chiou SH; Hsieh YS; Dong CY; Wang HW
    Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):504-10. PubMed ID: 25936596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses.
    Wiegell SR; Heydenreich J; Fabricius S; Wulf HC
    Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):280-5. PubMed ID: 22092730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternatives to Outdoor Daylight Illumination for Photodynamic Therapy--Use of Greenhouses and Artificial Light Sources.
    Lerche CM; Heerfordt IM; Heydenreich J; Wulf HC
    Int J Mol Sci; 2016 Feb; 17(3):309. PubMed ID: 26938525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
    Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
    Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
    Wiegell SR; Haedersdal M; Philipsen PA; Eriksen P; Enk CD; Wulf HC
    Br J Dermatol; 2008 Apr; 158(4):740-6. PubMed ID: 18294318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect.
    Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM
    Photochem Photobiol; 1998 Jan; 67(1):140-9. PubMed ID: 9477772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intense pulse light and 5-ALA PDT: phototoxic effects in vitro depend on the spectral overlap with protoporphyrine IX but do not match cut-off filter notations.
    Maisch T; Moor AC; Regensburger J; Ortland C; Szeimies RM; Bäumler W
    Lasers Surg Med; 2011 Feb; 43(2):176-82. PubMed ID: 21384398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial 5-ALA photodynamic therapy and glioblastoma: Preclinical model development and preliminary results.
    Tetard MC; Vermandel M; Leroy HA; Leroux B; Maurage CA; Lejeune JP; Mordon S; Reyns N
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():218-224. PubMed ID: 26213327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated illumination at low fluence rate photodynamic therapy in mice.
    Middelburg TA; Van Zaane F; De Bruijn HS; Van Der Ploeg-van den Heuvel A; Sterenborg HJ; Neumann HA; De Haas ER; Robinson DJ
    Photochem Photobiol; 2010; 86(5):1140-6. PubMed ID: 20553407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.